跳至主要内容
临床试验/EUCTR2020-005087-66-NL
EUCTR2020-005087-66-NL进行中(未招募)1 期

The Effect of Enzalutamide on Oxycodone Metabolism in Men with Prostate Cancer - the ENZYME study

Deventer Hospital0 个研究点目标入组 24 人开始时间: 2020年12月14日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • - Males aged = 18 years;
  • - Diagnosed prostate cancer;
  • - Treated with enzalutamide 160 mg once daily for 40 days (arm 1)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 8
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 16

排除标准

  • - a body mass index (BMI) outside the range of 18 to 30 kg/m2;
  • - known metastases in the liver that would affect drug metabolism;
  • - Child-Pugh classification B or C that would affect drug metabolism;
  • - known CYP3A4 or CYP2D6 polymorphisms that would affect drug metabolism (patients with a known CYP3A4 or CYP2D6 polymorphism afterwards will be replaced);
  • - known moderate-severe renal dysfunction (GFR <60 ml/min/1.73m2) that would affect drug metabolism;
  • - gastrointestinal disorders that would potentially alter absorption;
  • - previous gastric bypass or gastric band surgery;
  • - known allergy, hypersensitivity or intolerance to normal-release oxycodone;
  • - a history of drug abuse or treatment for abuse;
  • - dose-reduction or =5 successive days of treatment interruption of enzalutamide within 40 days prior to the study day (arm 1);
  • - treatment with enzalutamide within 40 days prior to the study day (arm 2);
  • - use of oxycodone normal-release within 48 hours prior to oxycodone intake or use of oxycodone extended-release within 4 days prior to oxycodone intake;
  • - use of other medication that would affect oxycodone metabolism, see section 5.2 and appendix B;
  • - use of other medication that would affect enzalutamide metabolism, see section 5.2 and appendix B (arm 1).

研究者

相似试验

The Effect of the Concomitant Use of Enzalutamide... | 临床试验